Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Lutetium-(177Lu)-oxodotreotide

Anaemia: case report

    • 6 Accesses

    This is a preview of subscription content, log in to check access.

    Reference

    1. Rudisile S, et al. Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival. BMC Cancer 19: No. 1, 8 Aug 2019. Available from: URL: http://doi.org/10.1186/s12885-019-6000-y

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Lutetium-(177Lu)-oxodotreotide. Reactions Weekly 1790, 151 (2020). https://doi.org/10.1007/s40278-020-74770-5

    Download citation